Dr. Kohta Saito, MD, MPH

Dr. Saito practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Saito's NPI, 1225262074, was assigned on May 7, 2009. Dr. Saito graduated from Harvard Medical School in 2009. Dr. Saito holds New York license 264661.

Dr. Saito's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Saito's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Saito to 2 more clinical labs and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Saito practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Saito's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Saito is board certified in infectious disease by the American Board of Internal Medicine. Dr. Saito is licensed in New York.

Dmand AI lists acute skin infection, endocarditis, joint or bone infection and pneumonia among the conditions Dr. Saito treats.

CMS data shows 236 Medicare services from Dr. Saito across 7 procedure codes in 2024, for 94 Medicare patients. Medicare paid $21,949 for them.

CMS counts 94 Medicare patients who saw Dr. Saito in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 3.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Saito's median patient age at 69, with 68% women.

In 2024, Dr. Saito wrote 285 Medicare Part D claims for 37 patients. 98% of them were for generic drugs. CMS names the drug for 211 of them, across 5 drugs with 11 or more claims each, at $5,963 in total drug cost. In 2023, CMS named 111 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Saito for performance year 2024, reported through an alternative payment model (APM). Dr. Saito accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Saito as offering telehealth.

Dmand AI links 12 papers to Dr. Saito, published from 2014 to 2022. 2016 was the busiest year, with 2. The most frequent topics are Mycobacterium tuberculosis, Antitubercular Agents and Tuberculosis. Dr. Saito has published most often in ACS Infect Dis. Dr. Saito's most frequent co-authors are Lee E. Morris, MD, Rosemary Soave, MD and Jun Zhang, MD.

Dr. Saito graduated from Harvard Medical School in 2009.

Dr. Saito is in network with 15 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.